The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,637.00
Bid: 1,635.50
Ask: 1,636.50
Change: -3.50 (-0.21%)
Spread: 1.00 (0.061%)
Open: 1,638.50
High: 1,647.00
Low: 1,634.00
Prev. Close: 1,640.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

22 Jan 2020 09:51

UPDATE 1-GSK appeal against fine over 'pay-for-delay' drug deals faces EU rebuke

(adds details, background)BRUSSELS, Jan 22 (Reuters) - British drugmaker GlaxoSmithKline may have harmed competition with payments it made to generic drugmakers to delay the launch of cheap copies of an antidepressant, according to an adviser to ...

Read more
22 Jan 2020 09:31

UPDATE 2-FTSE marks third straight day in the red

* FTSE 100 down 0.5%, FTSE 250 up 0.1%* Multinationals biggest drag on main index* Berkeley leads housebuilders higher* TUI, Burberry also weigh down bluechips* Ted Baker slides among smallcaps (Adds company news items, updates share moves)By Shashw...

Read more
22 Jan 2020 09:21

UK BROKER RATINGS SUMMARY: Berenberg Downgrades Unilever To Hold

UK BROKER RATINGS SUMMARY: Berenberg Downgrades Unilever To Hold

Read more
22 Jan 2020 08:52

"Pay-for-delay" deals over drug generics unlawful- EU court adviser

BRUSSELS, Jan 22 (Reuters) - An adviser to the European Court of Justice said on Wednesday that an agreement to settle a patent dispute between a pharmaceutical company and generic competitors may harm competition.The case relates to an agreement ...

Read more
21 Jan 2020 14:49

US Regulator Grants Priority Review Of Glaxo's Belantamab Mafodotin

US Regulator Grants Priority Review Of Glaxo's Belantamab Mafodotin

Read more
21 Jan 2020 13:00

Pharma firms not making enough progress against superbugs - report

By Kate KellandLONDON, Jan 21 (Reuters) - Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed great enough to tackle the global health threat posed by superbugs, a key benchmark analysis found on...

Read more
21 Jan 2020 12:48

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Read more
17 Jan 2020 09:07

UPDATE 2-FTSE 100 hits five-month high on China GDP and weak pound

* FTSE 100 rises 0.9%, FTSE 250 up 0.8%* China GDP in line with expectations* Weak UK retails sales bolster rate cut expectations* NMC Health, IAG among top blue-chip gainers* Among midcaps, motor insurer Hastings slides (Adds news items, analyst co...

Read more
16 Jan 2020 12:58

Thursday broker round-up

(Sharecast News) - Diageo: Jefferies downgrades to hold with a target price of 3,600p

Read more
16 Jan 2020 12:57

Barclays downgrades GlaxoSmithKline to 'underweight'

(Sharecast News) - Barclays downgraded its stance on GlaxoSmithKline shares to 'underweight' from 'equalweight' on Thursday, as it said 2020 looks set to be a much tougher investment year of little growth.

Read more
16 Jan 2020 09:38

UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight

UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight

Read more
16 Jan 2020 08:03

LONDON BRIEFING: AB Foods Reports Sales Rises Across Portfolio

LONDON BRIEFING: AB Foods Reports Sales Rises Across Portfolio

Read more
15 Jan 2020 09:20

UPDATE 2-Defensive stocks buoy FTSE 100 before U.S.-China trade deal

* FTSE 100 up 0.3%, FTSE 250 down 0.2%* U.S. tariffs on China to remain in place for now* Tullow Oil drags midcaps lower* Banks drop on rate cut bets (Adds company news items, updates to closing prices)By Shashwat Awasthi and Muvija MJan 15 (Reuters...

Read more
13 Jan 2020 09:19

Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On

Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On

Read more
9 Jan 2020 09:34

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts SIG After Profit Warning

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts SIG After Profit Warning

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.